|
|
Article: Concurrent antiphospholipid syndrome and sutaneous sarcoidosis due to interferon alfa and ribavirin treatment for hepatitis C.(Case study)
- Article from:
- Journal of Drugs in Dermatology
- Article date:
- September 1, 2009
- Author:
CopyrightCOPYRIGHT 2009 Journal of Drugs in Dermatology, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
ABSTRACT
Autoimmune phenomena are common in both hepatitis C infection and interferon alfa treatment; however, the development of antiphospholipid syndrome is rare. This article reports the case of a patient who developed antiphospholipid syndrome in addition to cutaneous sarcoidosis in the setting of pegylated interferon alfa and ribavirin treatment for hepatitis C.
INTRODUCTION
Hepatitis C virus (HCV) remains a significant pathogen in the United States (U.S.), with an estimated 1.3% of the population infected. (1) The majority of patients exposed to HCV develop chronic infection, with a subset developing cirrhosis and hepatocellular ...